Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,474Revenue (TTM) $M9,411Net Margin (%)-14.8Altman Z-Score0.1
Enterprise Value $M31,658EPS (TTM) $-6.9Operating Margin %-4.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-25.1Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %23.8Quick Ratio1.0Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %36.3Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow2.2y-y EBITDA Growth Rate %-38.2ROA % (ttm)-3.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-31.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M158ROIC % (ttm)-2.8Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VRX is held by these investors:



VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DE SCHUTTER RICHARD UDirector 2017-05-11Buy20,000$13.9-7.7view
DE SCHUTTER RICHARD UDirector 2017-03-15Buy10,000$10.818.8view
ValueAct Capital Master Fund, 2017-03-14Buy3,000,000$10.8218.58view
Herendeen PaulEVP and CFO 2017-03-14Buy24,000$10.7219.68view
Pershing Square Capital ManageDirector 2017-03-13Sell18,114,432$1116.64view
Ross Thomas W. Sr.Director 2016-12-14Buy5,000$14.73-12.9view
Pershing Square Capital ManageDirector 2016-12-12Sell3,476,690$14.85-13.6view
KARABELAS ARGERIS NDirector 2016-08-11Buy4,000$24.65-47.95view
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-47.42view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-47.59view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution May 22 2017 
Francis Chou Buys Pharmaceutical Stocks, Including Valeant May 17 2017 
Safirstein Metcalf LLP and HGT Law Updates Investors on Valeant Pharmaceuticals International Inc. I May 15 2017 
Valeant Pharmaceuticals To Present At Health Care Conferences May 10 2017 
Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Sol May 08 2017 
Bill Ackman Comments on Valeant in Annual Shareholder Letter May 08 2017 
Bill Ackman's 2017 Shareholder Letter and Portfolio Commentary May 08 2017 
Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership May 05 2017 
Hiding in Plain Sight May 05 2017 
Bill Ackman Is Back to Black May 02 2017 

More From Other Websites
Top 3 Companies Owned by Valeant (VRX) May 26 2017
Valeant's Numbers: Are They As Good As They Seem? May 25 2017
Valeant and Gilead: Beaten Down Bargains or Truly Terrible? May 23 2017
Time to Buy Valeant Pharmaceuticals May 23 2017
3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter May 22 2017
Eyegate Pharma stock surges 11% after receiving Valeant milestone payment May 22 2017
Bausch + Lomb Introduces renu® Advanced Formula Multi-Purpose Solution May 22 2017
3 Value Stocks for Ambitious Investors May 21 2017
Ackman has ‘something to prove’ after Valeant mistake May 20 2017
Bill Ackman Details Missteps With Valeant Investment May 19 2017
Valeant Pharmaceuticals: Intrigued…Really? May 19 2017
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA May 19 2017
5 Things You Must Know Before the Market Opens Friday May 19 2017
Humbled by Valeant, Ackman goes back to basics May 18 2017
SALT Spotlight: Ackman Explains His Valeant 'Mistake' May 18 2017
It's the Truth: Valeant Pharmaceuticals' Debt Situation Is Worse Now Than a Year Ago May 18 2017
Pershing Square Trims Mondelez, APD and Obviously Valeant: 13F Filing May 17 2017
Stocks Billionaire Bill Ackman Is Selling Now May 17 2017
Allergan's Irritable Bowel Drug Viberzi Approved in Canada May 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)